Caitong International Asset Management Co. Ltd Sells 976 Shares of Addus HomeCare Corporation $ADUS

Caitong International Asset Management Co. Ltd lowered its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 77.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 279 shares of the company’s stock after selling 976 shares during the quarter. Caitong International Asset Management Co. Ltd’s holdings in Addus HomeCare were worth $32,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of ADUS. Nuveen LLC bought a new position in shares of Addus HomeCare during the 1st quarter worth approximately $16,155,000. Wellington Management Group LLP lifted its position in shares of Addus HomeCare by 25.8% during the 1st quarter. Wellington Management Group LLP now owns 471,935 shares of the company’s stock worth $46,670,000 after buying an additional 96,823 shares in the last quarter. Allianz Asset Management GmbH lifted its position in shares of Addus HomeCare by 1,229.4% during the 1st quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company’s stock worth $9,978,000 after buying an additional 93,308 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Addus HomeCare by 18.3% during the 1st quarter. Principal Financial Group Inc. now owns 475,818 shares of the company’s stock worth $47,054,000 after buying an additional 73,720 shares in the last quarter. Finally, Invesco Ltd. lifted its position in shares of Addus HomeCare by 19.8% during the 1st quarter. Invesco Ltd. now owns 414,705 shares of the company’s stock worth $41,010,000 after buying an additional 68,585 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Analyst Ratings Changes

ADUS has been the topic of several recent analyst reports. TD Cowen lifted their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Stephens reissued an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a research report on Wednesday, September 3rd. Barclays lifted their price target on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a report on Tuesday, August 19th. UBS Group assumed coverage on shares of Addus HomeCare in a report on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 price target on the stock. Finally, Royal Bank Of Canada lifted their price target on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an “outperform” rating in a report on Friday, August 22nd. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $137.50.

Addus HomeCare Stock Up 0.8%

Addus HomeCare stock opened at $121.63 on Monday. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The firm has a market capitalization of $2.24 billion, a price-to-earnings ratio of 26.85, a P/E/G ratio of 1.86 and a beta of 0.86. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. The firm has a 50 day simple moving average of $114.83 and a 200 day simple moving average of $111.47.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. During the same period in the previous year, the business earned $1.35 EPS. Addus HomeCare’s revenue was up 21.8% compared to the same quarter last year. On average, analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares in the company, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the transaction, the executive vice president owned 56,980 shares of the company’s stock, valued at $6,656,403.60. This represents a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,310 shares of company stock worth $3,958,375. Corporate insiders own 4.50% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.